Semaglutide* Semaglutide is an FDA-approved injectable medication that was originally developed as a treatment for type 2 diabetes, but has been tremendously effective for weight loss
Patients should specifically inform their doctor if they have a history of the following conditions : thyroid disorders or thyroid nodules, pancreatitis or elevated pancreatic enzymes, kidney disease, liver disease, diabetic retinopathy, depression or suicidal ideation, gastroparesis or severe gastrointestinal disorders, or gallbladder disease
Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice
Typically, the drug's expiration date is 24 months from the date of manufacture, as long as its stored properly in the refrigerator (36F46F)
Available from: Pontes FSC, de Souza LL, Ucha DCC, Joaquim AMC, do Nascimento LS, da Mata Rezende DDS, Pontes HAR (2018) Melanotic neuroectodermal tumor of infancy of the jaw bones: update on the factors influencing survival and recurrence
doi: 10.3389/fendo.2024.1445878 62 WintherKHRaymanMPBonnemaSJHegedsL